Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ANP32B contributors: mct - updated : 23-02-2015
HGNC name acidic (leucine-rich) nuclear phosphoprotein 32 family, member B
HGNC id 16677
EXPRESSION
Type
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
blood / hematopoieticspleen    
Cardiovascularheart   highly
Digestiveliver    
Endocrinepancreas   highly
Nervousbrain    
Reproductivemale systemprostate  highly
Respiratorylung   highly
Skin/Tegumentskin appendages    
Urinarykidney   highly
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Blood / Hematopoieticbone marrow   
Connectivebone   
Epithelialbarrier/lining   
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period embryo
Text testis carcinoma and muscle
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • two N terminal leucine rich repeats (LRR), that possesses histone chaperone activity and forms a curved structure with a parallel beta-sheet on the concave side and mostly helical elements on the convex side
  • C terminal acidic clusters, and variable anionic region, functioning as an inhibitor of histone acetylation
  • conjugated PhosphoP
    HOMOLOGY
    interspecies homolog to murine Anp32b
    homolog to Drosophila CG3961
    homolog to C.elegans Y65B4BL.5
    Homologene
    FAMILY
  • acidic (leucine-rich) nuclear phosphoprotein 32 family
  • LRR subfamily
  • CATEGORY chaperone/stress , protooncogene , receptor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm
    intracellular,nucleus,nucleoplasm
    intracellular,nucleus,nucleolus
    text
  • translocated partially to the nucleoli after heat shock
  • localize in the nucleus
  • basic FUNCTION
  • involved in antigen-mediated cellular responses, leukemogenesis and differentiation
  • participating in signal transduction directing nucleolar activities by regulating ribosomal RNA biosynthesis
  • shuttle phosphoprotein required for ELAVL1-mediated nucleocytoplasmic translocation of the CD83 mRNA by acting as an adaptor that links ELAVL1 and XPO1
  • novel substrate for caspase-3 and acts as a negative regulator for apoptosis
  • with other ANP32 proteins have been implicated in a broad array of physiological processes, including cell differentiation, apoptotic cell death, and cell proliferation
  • potential role for ANP32B in vascular development
  • inhibitory role of ANP32B against leukemic cell differentiation
  • potential role of ANP32B in regulating retinoic acid receptor signaling
  • ANP32A, ANP32B, ANP32E represent an important node of physiological regulation by virtue of their diverse biochemical activities
  • CELLULAR PROCESS cell life, differentiation
    PHYSIOLOGICAL PROCESS immunity/defense
    PATHWAY
    metabolism
    signaling signal transduction
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • binding to RNA polymerase 1
  • KLF5 interacts with the novel histone chaperone acidic nuclear phosphoprotein 32B (ANP32B), leading to transcriptional repression of a KLF5-downstream gene
  • histone chaperone that specifically bound to the transcription factor KLF5, leading to transcriptional repression of KLF5-downstream genes through inhibition of promoter histone acetylation
  • direct substrate of caspase-3 and it is primarily cleaved at the sequence of Ala-Glu-Val-Asp, after Asp-163
  • interaction of ANP32B with the core histones H3-H4 occurs on its concave side, and both the acidic and hydrophobic residues that compose the concave surface are critical for histone binding
  • direct substrate for CASP3 and acted as a negative regulator for leukemic cell apoptosis
  • might exert this role through inhibiting the all-trans retinoic acid (ATRA)dependent transcriptional activity of retinoic acid receptor (RARA)
  • TNFRSF13B binds the cytokines TNFSF13B and ANP32B
  • inhibit the expression of the anti&
  • 8209;apoptotic protein BCL2
    cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    correlates with shortened patient survival
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
  • ANP32B mRNA expression in human breast cancers may serve as a prognostic marker
  • Therapy target
    SystemTypeDisorderPubmed
    cancerhemopathy 
    may serve as a potential therapeutic target for leukemia treatment
    ANIMAL & CELL MODELS
  • surviving Anp32b-deficient mice showed reduced viability due to variable defects in various organ systems